Genetic Alterations in Glioma

Por Bralten, Linda B. C., French, Pim J.
Publicado em 2011

ATCT-31 CENTRAL RADIOLOGY REVIEW OF THE BELOB TRIAL: TREATMENT WITH BEVACIZUMAB IN RECURRENT GLIOBLASTOMA IS ASSOCIATED WITH MORE FREQUENT NON-ENHANCING PROGRESSION

Por Smits, Marion, Bralten, Linda, Jasperse, Bas, Taal, Walter, Gahrmann, Renske, Walenkamp, Annemiek, Oosterkamp, Rianne, Vernhout, Rene, van der Holt, Bronno, van den Bent, Martin
Publicado no Neuro Oncol (2015)

Absence of Common Somatic Alterations in Genes on 1p and 19q in Oligodendrogliomas

Por Bralten, Linda B., Nouwens, Stephan, Kockx, Christel, Erdem, Lale, Hoogenraad, Casper C., Kros, Johan M., Moorhouse, Michael J., Sillevis Smitt, Peter A., van der Spek, Peter, van Ijcken, Wilfred, Stubbs, Andrew, French, Pim J.
Publicado em 2011

Exon Expression Arrays as a Tool to Identify New Cancer Genes

Por Schutte, Mieke, Elstrodt, Fons, Bralten, Linda B. C., Nagel, Jord H. A., Duijm, Elza, Hollestelle, Antoinette, Vuerhard, Maartje J., Wasielewski, Marijke, Peeters, Justine K., van der Spek, Peter, Sillevis Smitt, Peter A., French, Pim J.
Publicado em 2008

AT-55 FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND F...

Por Taal, Walter, Enting, Roelien, Taphoorn, Martin, Smits, Marion, Dubbink, Hendrikus, Beerepoot, Laurens, Hanse, Monique, Bralten, Linda, Oosterkamp, Hendrika, Walenkamp, Annemiek, Buter, Jan, Honkoop, Aafke, Boerman, Dolf, de Vos, Filip, Bromberg, Jacoline, Vernhout, Rene, van der Holt, Bronno, van den Bent, Martin
Publicado em 2014